´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ ⸳ 20Áֳ⠱â³ä Ãá°èÇмú´ëȸ : 2022-03-04±³À°ÀÏÀÚ : 2022-03-04
±³À°Àå¼Ò : ¼¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽÇ
±³À°ÁÖÁ¦ :
´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ ⸳ 20Áֳ⠱â³ä Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ¿ì¿ï.Á¶¿ïº´ÇÐȸ (ÀÌ»çÀåÁ¦)
´ã´çÀÚ : ¿ì¿µ¼·
¿¬¶ôó : 02-3779-1250
À̸ÞÀÏ :
webmaster@thekasad.or.kr ±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 11 ½Ã°£ 45ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í »çÀüµî·Ï: Á¤È¸¿ø 5¸¸¿ø, ÁØȸ¿ø 3¸¸¿ø, ºñȸ¿ø 6¸¸¿ø, Æò»ýȸ¿ø ¸éÁ¦ ´çÀϵî·Ï: Á¤È¸¿ø 6¸¸¿ø, ÁØȸ¿ø 4¸¸¿ø, ºñȸ¿ø 8¸¸¿ø, Æò»ýȸ¿ø 1¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-04 ÄÁº¥¼ÇȦ 09:30~09:50 Polarity in mood and its diagnostic evolution °í¿µÈÆ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 03-04 ÄÁº¥¼ÇȦ 09:50~10:10 Classification in bipolar disorder ¹Ú¿µ¹Î(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 03-04 ÄÁº¥¼ÇȦ 10:10~10:40 Mixed features: Evolution of the concept ¹®Àº¼ö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 03-04 ÄÁº¥¼ÇȦ 10:55~11:40 History of mood disorder in Korea and the way to go ¹Ú¿ø¸í(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 03-04 ÄÁº¥¼ÇȦ 11:40~12:10 Better choice for schizophrenia ±è¼±¹Ì(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 03-04 ÄÁº¥¼ÇȦ 12:10~12:40 Better choice for bipolar disorder ¿ì¿µ¼·(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 03-04 ÄÁº¥¼ÇȦ 13:40~13:55 ¡®Irritability¡¯ as a symptom of depression for children and adolescents? À̹®¼ö(°í·ÁÀÇ´ë)
±³À°½Ã°£ 03-04 ÄÁº¥¼ÇȦ 13:55~14:10 What can tell the differences between bipolar disorder and ADHD? ½É¼¼ÈÆ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 03-04 ÄÁº¥¼ÇȦ 14:10~14:25 Are there cognitive dysfunctions in bipolar disorder? ¿Õ¼º¹Î(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 03-04 ÄÁº¥¼ÇȦ 14:25~14:50 What is the vascular depression hypothesis? ¾öÀ¯Çö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 03-04 ÄÁº¥¼ÇȦ 14:50~15:50 Changes in preferred treatment strategies and medications over 20 years : Focus on KMAP-BP Àü´öÀÎ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 03-04 ÄÁº¥¼ÇȦ 16:00~16:20 Self-assessment and screening program Á¤¿µÀº(Á¦ÁÖÀÇ´ë)
±³À°½Ã°£ 03-04 ÄÁº¥¼ÇȦ 16:20~16:40 Informational self-help resources ÀÓÀº¼º(½Å¼¼°èÈ¿º´¿ø)
±³À°½Ã°£ 03-04 ÄÁº¥¼ÇȦ 16:40~17:10 Self-monitoring practices of bipolar patients È«Á¤¿Ï(Àͻ꺴¿ø)
±³À°½Ã°£ 03-04 ´ëȸÀÇ½Ç 09:30~09:50 Suicide rate and risk factors in pandemic °ÇÑ°íÀººñ(±¹¸³³ªÁÖº´¿ø)
±³À°½Ã°£ 03-04 ´ëȸÀÇ½Ç 09:50~10:10 Immunity, suicide and COVID-19: A linking pathway Àå½ÂÈ£(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 03-04 ´ëȸÀÇ½Ç 10:10~10:40 Suicide prevention during COVID-19 ±è¿øÇü(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 03-04 ´ëȸÀÇ½Ç 11:40~12:10 Progress in diagnosis and treatment for better outcome ¼ºÇü¸ð(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 03-04 ´ëȸÀÇ½Ç 12:10~12:40 Best practices in the use of long-acting injectable antipsychotics ÀÌÁ¤±¸(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 03-04 ´ëȸÀÇ½Ç 13:40~14:00 Child and adolescent ¾çÂù¸ð(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 03-04 ´ëȸÀÇ½Ç 14:00~14:20 Women ±è°æ¹Î(±¹¸³³ªÁÖº´¿ø)
±³À°½Ã°£ 03-04 ´ëȸÀÇ½Ç 14:20~14:50 Comorbid medical conditions ½ÉÀÎÈñ(µ¿³²±Ç¿øÀÚ·ÂÀÇÇпø)
±³À°½Ã°£ 03-04 ´ëȸÀÇ½Ç 14:50~15:20 DBT for mood disorder ±è¿ø(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 03-04 ´ëȸÀÇ½Ç 15:20~15:50 MBCT for depression ±¸º»ÈÆ(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 03-04 ´ëȸÀÇ½Ç 16:00~16:20 Psychosocial aspects of obesity ¼Û¹Î±Ô(¼º¸ð°ø°¨Á¤½Å°Ç°ÀÇÇаúÀÇ¿ø)
±³À°½Ã°£ 03-04 ´ëȸÀÇ½Ç 16:20~16:40 Common neurobiological underpinnings of obesity and mood disorders Á¤¸íÈÆ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 03-04 ´ëȸÀÇ½Ç 16:40~17:10 Management for comorbid obesity and mood disorders ¹Ú¼º¿ë(°è¿äº´¿ø)